Loring Wolcott & Coolidge Fiduciary Advisors’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-74
| Closed | -$5.68K | – | 568 |
|
|
2025
Q4 | $5.68K | Buy |
+74
| New | +$5.86K | ﹤0.01% | 513 |
|
|
2025
Q2 | – | Sell |
-26
| Closed | -$1.93K | – | 546 |
|
|
2025
Q1 | $1.93K | Buy |
+26
| New | +$2.16K | ﹤0.01% | 521 |
|
|
2024
Q4 | – | Sell |
-134
| Closed | -$11.3K | – | 573 |
|
|
2024
Q3 | $11.3K | Sell |
134
-18
| -12% | -$1.34K | ﹤0.01% | 494 |
|
|
2024
Q2 | $11.5K | Buy |
152
+134
| +744% | +$9.57K | ﹤0.01% | 484 |
|
|
2024
Q1 | $1.29K | Hold |
18
| – | – | ﹤0.01% | 550 |
|
|
2023
Q4 | $1.25K | Hold |
18
| – | – | ﹤0.01% | 541 |
|
|
2023
Q3 | $1.08K | Buy |
+18
| New | +$1.12K | ﹤0.01% | 591 |
|
|
2022
Q3 | – | Sell |
-254
| Closed | -$16K | – | 621 |
|
|
2022
Q2 | $16K | Buy |
+254
| New | +$16.8K | ﹤0.01% | 521 |
|
|
2020
Q4 | – | Sell |
-283
| Closed | -$11K | – | 788 |
|
|
2020
Q3 | $11K | Hold |
283
| – | – | ﹤0.01% | 508 |
|
|
2020
Q2 | $10K | Hold |
283
| – | – | ﹤0.01% | 501 |
|
|
2020
Q1 | $9K | Hold |
283
| – | – | ﹤0.01% | 550 |
|
|
2019
Q4 | $14K | Hold |
283
| – | – | ﹤0.01% | 567 |
|
|
2019
Q3 | $13K | Hold |
283
| – | – | ﹤0.01% | 550 |
|
|
2019
Q2 | $14K | Hold |
283
| – | – | ﹤0.01% | 542 |
|
|
2019
Q1 | $12K | Hold |
283
| – | – | ﹤0.01% | 551 |
|
|
2018
Q4 | $12K | Hold |
283
| – | – | ﹤0.01% | 556 |
|
|
2018
Q3 | $13K | Hold |
283
| – | – | ﹤0.01% | 523 |
|
|
2018
Q2 | $12K | Hold |
283
| – | – | ﹤0.01% | 537 |
|
|
2018
Q1 | $13K | Hold |
283
| – | – | ﹤0.01% | 569 |
|
|
2017
Q4 | $14K | Sell |
283
-15
| -5% | -$790 | ﹤0.01% | 546 |
|
|
2017
Q3 | $15K | Sell |
298
-20
| -6% | -$974 | ﹤0.01% | 532 |
|
|
2017
Q2 | $16K | Hold |
318
| – | – | ﹤0.01% | 513 |
|
|
2017
Q1 | $15K | Hold |
318
| – | – | ﹤0.01% | 514 |
|
|
2016
Q4 | $15K | Hold |
318
| – | – | ﹤0.01% | 492 |
|
|
2016
Q3 | $13K | Hold |
318
| – | – | ﹤0.01% | 521 |
|
|
2016
Q2 | $11K | Sell |
318
-74
| -19% | -$2.89K | ﹤0.01% | 537 |
|
|
2016
Q1 | $15K | Buy |
392
+74
| +23% | +$2.77K | ﹤0.01% | 506 |
|
|
2015
Q4 | $14K | Hold |
318
| – | – | ﹤0.01% | 537 |
|
|
2015
Q3 | $16K | Hold |
318
| – | – | ﹤0.01% | 508 |
|
|
2015
Q2 | $16K | Sell |
318
-390
| -55% | -$18.5K | ﹤0.01% | 508 |
|
|
2015
Q1 | $32K | Sell |
708
-202
| -22% | -$9.08K | ﹤0.01% | 480 |
|
|
2014
Q4 | $44K | Buy |
910
+30
| +3% | +$1.43K | ﹤0.01% | 440 |
|
|
2014
Q3 | $42K | Hold |
880
| – | – | ﹤0.01% | 428 |
|
|
2014
Q2 | $44K | Buy |
880
+433
| +97% | +$20.3K | ﹤0.01% | 444 |
|
|
2014
Q1 | $21K | Buy |
447
+57
| +15% | +$2.62K | ﹤0.01% | 490 |
|
|
2013
Q4 | $19K | Buy |
+390
| New | +$17.5K | ﹤0.01% | 475 |
|
Other funds holding MET
Loring Wolcott & Coolidge Fiduciary Advisors's MET Position: Q1 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of MetLife (MET) in Q1 2026, closing a stake of 74 shares — an estimated $5.68K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MET in Q4 2013 and held it in 36 quarters. The position peaked at $44K in Q4 2014. 1,384 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 74 MetLife shares in Q1 2026, an estimated $5.68K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MetLife in Q4 2013 and held it in 36 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's MetLife position peaked at $44K in Q4 2014.
- 1,384 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.